García-Ortega DY, Clara-Altamirano MA, Gómez-Pedraza A, Martínez-Said H, Maciel-Miranda A, Caro-Sánchez CHS, Cuellar-Hubbe M, Partida-Nava GV

Language: Spanish
References: 13
Page: 354-357
PDF size: 185.26 Kb.

ABSTRACT

Introduction: Primary sacral tumors are rare, treatment in most cases is surgical with or without adjuvant radiotherapy; oncology and functional results are usually adverse with a high rate of complications. Material and methods: We conducted a retrospective, analytical and observational studies that includes 22 cases treated between 2000 and 2017, analyzed their characteristics demographic, the type of treatment received, and the oncological, functional results and the rate of complications were analized. Results: 22 patients were subjected to sacrectomy with posterior approah because of cordoma (13 patients), giant cell tumour (three patients) and other (six patients). Three total sacrectomies, 13 partial sacrectomies, two hemisacrectomies and four sacrectomies enlarged were performed. The mean surgical time was 229 minutes, with an average bleeding of 2,100 cm³, the average tumour size was 13.8 cm (6-30cm); 10 patients were presented with complications, eight by surgical site infection, one sacral hernia and one osteomyelitis. Overall survival was 44.4 months. Conclusions: Treatment of sacral tumors is complex, requires a multidisciplinary team; the oncological result is adequate when you get free margins of neoplasia, the functional results will be determined by the type of resection, and the rate of complications is high however is the best alternative healing in our hospital.

REFERENCES

1. Feldenzer JA, McGauley JL, McGillicuddy JE. Sacral and presacral tumors: problems in diagnosis and management. Neurosurgery. 1989; 25(6): 884-91.

2. Fourney DR, Rhines LD, Hentschel SJ, Skibber JM, Wolinsky JP, Weber KL, et al. En bloc resection of primary sacral tumors: classification of surgical approaches and outcome. J Neurosurg Spine. 2005; 3(2): 111-22.

3. Todd L, Yaszemski M, Currier B, Fuchs B, Kim C, Sim F. Bowel and bladder function after major sacral resection. Clin Orthop Relat Res. 2002; 397: 36-9.

4. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992; 13(10): 606-8.

5. Chen KW, Yang HL, Lu JY, Liu J, Chen X. Prognostic factors of sacral chordoma after surgical therapy: a study of 36 patients. Spinal Cord. 2010; 48(2): 166-71.

6. Biagini R, Ruggieri P, Mercuri M, Capanna R, Briccoli A, Perin S, et al. Neurologic deficit after resection of the sacrum. Chir Organi Mov. 1997; 82(4): 357-72.

7. Nakai S, Yoshizawa H, Kobayashi S, Maeda K, Okumura Y. Anorectal and bladder function after sacrifice of the sacral nerves. Spine (Phila Pa 1976). 2000; 25(17): 2234-9.

8. Gunterberg B, Norlén L, Stener B, Sundin T. Neurologic evaluation after resection of the sacrum. Invest Urol. 1975; 13(3): 183-8.

9. Ohata N, Ozaki T, Kunisada T, Morimoto Y, Tanaka M, Inoue H. Extended total sacrectomy and reconstruction for sacral tumor. Spine (Phila Pa 1976). 2004; 29(6): E123-6.

10. Randall RL, Bruckner J, Lloyd C, Pohlman TH, Conrad EU 3rd. Sacral resection and reconstruction for tumors and tumor-like conditions. Orthopedics. 2005; 28(3): 307-13.

11. Sahakitrungruang C, Chantra K, Dusitanond N, Atittharnsakul P, Rojanasakul A. Sacrectomy for primary sacral tumors. Dis Colon Rectum. 2009; 52(5): 913-8.

12. Sar C, Eralp L. Surgical treatment of primary tumors of the sacrum. Arch Orthop Trauma Surg. 2002; 122(3): 148-55.

13. Wuisman P, Lieshout O, Sugihara S, van Dijk M. Total sacrectomy and reconstruction: oncologic and functional outcome. Clin Orthop Relat Res. 2000; 381: 192-203.